Kourosh Davarpanah is the Co-Founder and CEO of Inato, a healthcare technology company expanding access to clinical trials by unlocking the potential of community research sites. Since 2016, he has led Inato’s growth into a platform that helps biopharma companies and CROs connect with underutilized sites and deliver trials more effectively. With a background in physics and management science from École Polytechnique and Columbia University, Kourosh combines deep technical expertise with entrepreneurial vision. Previously, he co-founded Fleet Impact, contributed to the design of NeuCoin, and worked as an analyst at Lazard.